Morgan Stanley closes deal to exit Brazos Delaware II for $1.6bn
The purchase price of $1.6 billion represents an 8x EBITDA multiple based on projected 2027 EBITDA
15 June 2026•2 mins read
The purchase price of $1.6 billion represents an 8x EBITDA multiple based on projected 2027 EBITDA
PE spots opportunities in horses healthcare: 5 deals
18 hours ago · 3 mins read
Blackstone spots AI and low-cost interceptors opportunity with Falcata defense platform
21 October 2026 · 2 mins read
Exclusive: MSCP bets on aging water infrastructure with The Rapid Group investment
20 October 2026 · 3 mins read
PE eyes cardiometabolic care amid GLP-1 boom, outpatient shifts: 6 deals
16 October 2026 · 3 mins read
Exclusive: Vista agrees to acquire HID's PKI business unit
16 October 2026 · 3 mins read
ArchiMed’s Denis Ribon details €1.5bn fund deployment plans as AI reshapes healthcare
14 October 2026 · 4 mins read
Exclusive: ATL Partners forms Precise Aerospace & Defense platform
13 October 2026 · 3 mins read
